EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Postbiotic potential of Lactococcus lactis CNCM I‐5388 in alleviating visceral pain in female rat through GABA production: The innovative concept of the “active‐ GAD bag”

Pedro Gomes iD, Valérie Laroute iD, Catherine Beaufrand iD, Valérie Bézirard iD, Nathalie Aubry iD, Chloé Liebgott iD, Jonna E B Koper iD, Elyse Parent, Nabil Bosco iD, Nathalie Ballet iD, Sophie Legrain-Raspaud iD, Marie-Line Daveran-Mingot iD und 4 weitere

The FASEB Journal · 28.02.2025 · 39 (4)

DOI: 10.1096/fj.202401125rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 22.02.2025. Verfasst von Pedro Gomes und 15 weiteren Autor:innen. Beteiligte Einrichtung: Toulouse Biotechnology Institute (TBI), Université de Toulouse, CNRS, INRAE, INSA, Toulouse, France. Hauptthemen laut MEDLINE: Lactococcus lactis, gamma-Aminobutyric Acid, Visceral Pain, Glutamate Decarboxylase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Lesaffre International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irritable bowel syndrome (IBS) is a multifactorial disorder of the gut‐brain axis, characterized by visceral hypersensitivity (VH). Psychobiotics, through GABA synthesis, are good candidates to alleviate gastrointestinal discomfort. Here, we analyzed the GABA‐producer Lactococcus lactis CNCM I‐5388 as an active‐enzyme postbiotic to relieve VH mediated by psychological stress. L. lactis CNCM I‐5388 was inactivated by ethanol while maintaining its glutamate decarboxylase (GAD) activity. This EtOH‐treated nonviable form was given daily orally for 1, 5, or 10 days to female Wistar rats in comparison with viable L. lactis CNCM I‐5388 or vehicle. Visceral sensitivity was measured by electromyography before and after partial restraint stress (PRS). GABA was quantified in the stomach collected from rats and in the gastric compartment of TIM‐1 human gut model in fed state. A daily treatment for 5 and 10 days by L. lactis CNCM I‐5388 both in its viable and nonviable forms counteracted VH promoted by PRS. However, only viable L. lactis CNCM I‐5388 tended to reduce VH after a single administration. After 5‐day treatment, only under PRS conditions, the production of GABA within the stomach was enhanced in rats treated with viable or nonviable L. lactis CNCM I‐5388. This increase was confirmed by using the TIM‐1 human gut model. We found that a postbiotic with an active‐GAD enzyme of L. lactis CNCM I‐5388, similarly to its viable psychobiotic form, exerts anti‐VH properties in an IBS‐like rat model. These effects are associated with GABA production in the stomach where the low pH promotes GAD activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactococcus lactisgamma-Aminobutyric AcidVisceral PainGlutamate DecarboxylaseProbioticsIrritable Bowel SyndromeAnimalsFemaleRats, WistarRatsHumansStress, Psychological

Stichwörter der Autor:innen

gamma (γ)‐amino butyric acidintestinal bowel syndromepostbioticvisceral hypersensitivity

Substanzen

gamma-Aminobutyric AcidGlutamate Decarboxylase

Autor:innen und Institutionen

  • Toulouse Biotechnology Institute (TBI), Université de Toulouse, CNRS, INRAE, INSA, Toulouse, France.
  • Toxalim (Research Centre in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France.
  • Lesaffre Institute of Science and Technology, Lesaffre International, Marcq-en-Barœul, France.

ORCID-Profile: Pedro Gomes, Valérie Laroute, Catherine Beaufrand, Valérie Bézirard, Nathalie Aubry, Chloé Liebgott, Jonna E B Koper, Nabil Bosco, Nathalie Ballet, Sophie Legrain-Raspaud, Marie-Line Daveran-Mingot, Vassilia Theodorou, Muriel Cocaign-Bousquet, Hélène Eutamene, Muriel Mercier-Bonin

Förderung

  • Lesaffre International

Zitieren

APA

Gomes, P., Laroute, V., Beaufrand, C., Bézirard, V., Aubry, N., Liebgott, C., Koper, J. E. B., Parent, E., Bosco, N., Ballet, N., Legrain-Raspaud, S., Daveran-Mingot, M. L., Theodorou, V., Cocaign-Bousquet, M., Eutamene, H., & Mercier-Bonin, M. (2025). Postbiotic potential of Lactococcus lactis CNCM I‐5388 in alleviating visceral pain in female rat through GABA production: The innovative concept of the “active‐ GAD bag”. The FASEB Journal, 39(4). https://doi.org/10.1096/fj.202401125rr

Vancouver

Gomes P, Laroute V, Beaufrand C, Bézirard V, Aubry N, Liebgott C, et al. Postbiotic potential of Lactococcus lactis CNCM I‐5388 in alleviating visceral pain in female rat through GABA production: The innovative concept of the “active‐ GAD bag”. The FASEB Journal. 2025;39(4). doi:10.1096/fj.202401125rr

BibTeX
@article{Gomes2025,
  author = {Gomes, Pedro and Laroute, Valérie and Beaufrand, Catherine and Bézirard, Valérie and Aubry, Nathalie and Liebgott, Chloé and Koper, Jonna E B and Parent, Elyse and Bosco, Nabil and Ballet, Nathalie and Legrain-Raspaud, Sophie and Daveran-Mingot, Marie-Line and Theodorou, Vassilia and Cocaign-Bousquet, Muriel and Eutamene, Hélène and Mercier-Bonin, Muriel},
  title = {Postbiotic potential of Lactococcus lactis CNCM I‐5388 in alleviating visceral pain in female rat through GABA production: The innovative concept of the “active‐ GAD bag”},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {4},
  doi = {10.1096/fj.202401125rr}
}
Kostenlos starten →